2015
DOI: 10.3324/haematol.2015.126128
|View full text |Cite
|
Sign up to set email alerts
|

Identification of novel microRNA signatures linked to acquired aplastic anemia

Abstract: ABSTRACTstrate that down-regulation of miR-126-3p and miR-145-5p promotes CD4+ and CD8 + T-cell activation by increasing MYC and PIK3R2 expression levels and T-cell proliferation, of potential importance in the pathogenesis of AA. Our results provide a pharmacological rationale for the potential use of synthetic miRNA mimics to limit disease.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

6
35
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 31 publications
(41 citation statements)
references
References 57 publications
6
35
0
Order By: Relevance
“…Nonetheless, our data strongly suggest that aberrant miRNA expression was disease-related, especially as the restoration of miRNA levels was observed after IST. In our recent work, we identified concurrent downregulation of 4 miRNAs (miR-126-3p, miR-145-5p, miR-199a-5p, and miR-223-3p) in both CD4 + and CD8 + T cells from AA patients, 14 but dysregulation of the 4 miRNAs was not observed in AA plasma samples in the study herein. Previous reports in autoimmune diseases 12,20,[52][53][54][55][56][57][58][59] and cancers, [60][61][62][63] have also demonstrated discrepancies of expression profiles between cellular and circulating miRNAs.…”
Section: Discussionmentioning
confidence: 79%
See 2 more Smart Citations
“…Nonetheless, our data strongly suggest that aberrant miRNA expression was disease-related, especially as the restoration of miRNA levels was observed after IST. In our recent work, we identified concurrent downregulation of 4 miRNAs (miR-126-3p, miR-145-5p, miR-199a-5p, and miR-223-3p) in both CD4 + and CD8 + T cells from AA patients, 14 but dysregulation of the 4 miRNAs was not observed in AA plasma samples in the study herein. Previous reports in autoimmune diseases 12,20,[52][53][54][55][56][57][58][59] and cancers, [60][61][62][63] have also demonstrated discrepancies of expression profiles between cellular and circulating miRNAs.…”
Section: Discussionmentioning
confidence: 79%
“…Indeed, miRNA expression profiles are cell-type specific. Of note, regardless of discrepancies between cellular and circulating miRNA profiles, we could observe some common miRNA signatures in both AA and MG, such as decreased miR-145-5p in T cells 14,64 and increased miR-150-5p in plasma specimens. 21 In conclusion, we demonstrate that expression levels of 3 dysregulated miRNAs in AA plasma associate with clinical parameters and normalize after IST, suggesting their use as potential biomarkers in AA.…”
Section: Discussionmentioning
confidence: 92%
See 1 more Smart Citation
“…23 Augmented expression of granzymes B and C and perforin in DGKζ -/mouse BM denotes an increase in cytotoxic T cells (CTL) similar to that described in AA patients. 24 Activated T lymphocytes cause BM destruction in AA; 25 DGKζ -/mice showed reduced BM cellularity ( Figure 1D). Analysis of the TER-119 + erythroid lineage populations did not show differences between DGKζ -/and WT mice ( Figure 1E).…”
Section: Resultsmentioning
confidence: 98%
“…Our results provide the first evidence that miR-126* promotes pGC apoptosis. Hosokawa et al (2015) demonstrated that miR-126* knockdown promotes proliferation and increases interferon-γ and granzyme B production in CD4+ and CD8+ T cells. In addition, overexpression of miR-126* significantly inhibits cell proliferation in thyroid cancer (Xiong et al 2015) and breast cancer cells (Rohde et al 2015).…”
Section: Discussionmentioning
confidence: 99%